The DOI matches its Crossref record; 326 of the 326 references it cites were found in a registry or an index.
Methamphetamine toxicity and messengers of death
Open accessAbstract
Methamphetamine (METH) is an illicit psychostimulant that is widely abused in the world. Several lines of evidence suggest that chronic METH abuse leads to neurodegenerative changes in the human brain. These include damage to dopamine and serotonin axons, loss of gray matter accompanied by hypertrophy of the white matter and microgliosis in different brain areas. In the present review, we summarize data on the animal models of METH neurotoxicity which include degeneration of monoaminergic terminals and neuronal apoptosis. In addition, we discuss molecular and cellular bases of METH-induced neuropathologies. The accumulated evidence indicates that multiple events, including oxidative stress, excitotoxicity, hyperthermia, neuroinflammatory responses, mitochondrial dysfunction, endoplasmic reticulum stress converge to mediate METH-induced terminal degeneration and neuronal apoptosis. When taken together, these findings suggest that pharmacological strategies geared towards the prevention and treatment of the deleterious effects of this drug will need to attack the various pathways that form the substrates of METH toxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric Oxide and Peroxynitrite in Health and Disease
Pacher, P., Beckman, J. S., & Liaudet, L. (2007) · Physiological Reviews · doi:10.1152/physrev.00029.2006 · Cited by 6,390
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110
Mitochondrial membrane permeabilization in cell death
Kroemer, G., Galluzzi, L., & Brenner, C. (2007) · Physiological Reviews · doi:10.1152/physrev.00013.2006 · Cited by 3,598 · cited 2×
“At physiological levels, Ca2+ released from the ER is taken up by mitochondria to enhance metabolite flow on the outer mitochondrial membrane and to increase ATP production (Kroemer et al., 2007).”
BackgroundWallace, D. C. (2005) · Annual Review of Genetics · doi:10.1146/annurev.genet.39.110304.095751 · Cited by 3,185
Transcriptional regulation by calcium, calcineurin, and NFAT
Hogan, P. G., Chen, L., Nardone, J., & Rao, A. (2003) · Genes & Development · doi:10.1101/gad.1102703 · Cited by 1,991
Autophagy: molecular machinery for self-eating
Yorimitsu, T., & Klionsky, D. J. (2005) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401765 · Cited by 1,535
Mechanisms of neurotransmitter release by amphetamines: A review
Sulzer, D., Sonders, M. S., Poulsen, N. W., & Galli, A. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.04.003 · Cited by 1,209
NMDA-dependent superoxide production and neurotoxicity
Lafon-Cazal, M., Pietri, S., Culcasi, M., & Bockaert, J. (1993) · Nature · doi:10.1038/364535a0 · Cited by 1,183
Cross-Talk between Two Cysteine Protease Families
Nakagawa, T., & Yuan, J. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.150.4.887 · Cited by 1,168
REGULATION OF GENE EXPRESSION BY REACTIVE OXYGEN
Dalton, T. P., Shertzer, H. G., & Puga, A. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.67 · Cited by 1,118
González-Scarano, F., & Martín-García, J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1527 · Cited by 1,097
Systemic infections and inflammation affect chronic neurodegeneration
Perry, V. H., Cunningham, C., & Holmes, C. (2007) · Nature Reviews Immunology · doi:10.1038/nri2015 · Cited by 1,027
Association of Dopamine Transporter Reduction With Psychomotor Impairment in Methamphetamine Abusers
Volkow, N. D., Chang, L., Wang, G.-J., Fowler, J. S., Leonido-Yee, M., Franceschi, D., Sedler, M. J., Gatley, S. J., Hitzemann, R., Ding, Y.-S., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.3.377 · Cited by 984
Endoplasmic Reticulum Stress Signaling in Disease
Marciniak, S. J., & Ron, D. (2006) · Physiological Reviews · doi:10.1152/physrev.00015.2006 · Cited by 945
Death receptor-induced cell killing
Thorburn, A. (2004) · Cellular Signalling · doi:10.1016/j.cellsig.2003.08.007 · Cited by 791
Structural Abnormalities in the Brains of Human Subjects Who Use Methamphetamine
Thompson, P. M., Hayashi, K. M., Simon, S. L., Geaga, J. A., Hong, M. S., Sui, Y., Lee, J. Y., Toga, A. W., Ling, W., & London, E. D. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0713-04.2004 · Cited by 760
Loss of Dopamine Transporters in Methamphetamine Abusers Recovers with Protracted Abstinence
Volkow, N. D., Chang, L., Wang, G.-J., Fowler, J. S., Franceschi, D., Sedler, M., Gatley, S. J., Miller, E., Hitzemann, R., Ding, Y.-S., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-23-09414.2001 · Cited by 754
Oxidative Stress and Cell Signalling
Poli, G., Leonarduzzi, G., Biasi, F., & Chiarpotto, E. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043365323 · Cited by 722
Striatal dopamine nerve terminal markers in human, chronic methamphetamine users
Wilson, J. M., Kalasinsky, K. S., Levey, A. I., Bergeron, C., Reiber, G., Anthony, R. M., Schmunk, G. A., Shannak, K., Haycock, J. W., & Kish, S. J. (1996) · Nature Medicine · doi:10.1038/nm0696-699 · Cited by 718
Major physical and psychological harms of methamphetamine use
DARKE, S., KAYE, S., McKETIN, R., & DUFLOU, J. (2008) · Drug and Alcohol Review · doi:10.1080/09595230801923702 · Cited by 675
Neurocognitive Effects of Methamphetamine: A Critical Review and Meta-analysis
Scott, J. C., Woods, S. P., Matt, G. E., Meyer, R. A., Heaton, R. K., Atkinson, J. H., & Grant, I. (2007) · Neuropsychology Review · doi:10.1007/s11065-007-9031-0 · Cited by 671
Kim, Y. S., & Joh, T. H. (2006) · Experimental & Molecular Medicine · doi:10.1038/emm.2006.40 · Cited by 655
The Endoplasmic Reticulum: Folding, Calcium Homeostasis, Signaling, and Redox Control
Görlach, A., Klappa, P., & Kietzmann, D. T. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.1391 · Cited by 615
McCann, U. D., Wong, D. F., Yokoi, F., Villemagne, V., Dannals, R. F., & Ricaurte, G. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-20-08417.1998 · Cited by 602 · cited 1×
“These abnormalities include persistent decreases in the levels of dopamine transporters (DAT) in the orbitofrontal cortex, dorsolateral prefrontal cortex, and the caudate-putamen (McCann et al., 1998, 2008; Sekine et al., 2003; Volkow et al., 2001a, 2001c).”
BackgroundEarly and Progressive Accumulation of Reactive Microglia in the Huntington Disease Brain
Sapp, E., Kegel, K. B., Aronin, N., Hashikawa, T., Uchiyama, Y., Tohyama, K., Bhide, P. G., Vonsattel, J. P., & Difiglia, M. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.2.161 · Cited by 540
Wagner, G. C., Ricaurte, G. A., Seiden, L. S., Schuster, C. R., Miller, R. J., & Westley, J. (1980) · Brain Research · doi:10.1016/0006-8993(80)91265-2 · Cited by 523
Davidson, C., Gow, A. J., Lee, T. H., & Ellinwood, E. H. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00054-6 · Cited by 521
Invited Review Free radicals and the pathobiology of brain dopamine systems
Cadet, J. L., & Brannock, C. (1998) · Neurochemistry International · doi:10.1016/s0197-0186(97)00031-4 · Cited by 499 · cited 1×
“DA metabolism by MAO is also accompanied by increased production of hydrogen peroxide which interacts with metal ions such as iron, whose level is elevated by METH treatment (Melega et al., 2007), to form toxic hydroxyl radicals (Cadet and Brannock, 1998).”
BackgroundSelf-citationRole for Excitatory Amino Acids in Methamphetamine-Induced Nigrostriatal Dopaminergic Toxicity
Sonsalla, P. K., Nicklas, W. J., & Heikkila, R. E. (1989) · Science · doi:10.1126/science.2563176 · Cited by 490
Ricaurte, G. A., Schuster, C. R., & Seiden, L. S. (1980) · Brain Research · doi:10.1016/0006-8993(80)90952-x · Cited by 490
Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain
Ricaurte, G. A., Guillery, R. W., Seiden, L. S., Schuster, C. R., & Moore, R. Y. (1982) · Brain Research · doi:10.1016/0006-8993(82)90198-6 · Cited by 479
Cytotoxic and genotoxic potential of dopamine
Stokes, A. H., Hastings, T. G., & Vrana, K. E. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990315)55:6<659::aid-jnr1>3.0.co;2-c · Cited by 469
Psychiatric Symptoms in Methamphetamine Users
Zweben, J. E., Cohen, J. B., Christian, D., Galloway, G. P., Salinardi, M., Parent, D., Iguchi, M., & Methamphetamine Treatment Project (2004) · The American Journal on Addictions · doi:10.1080/10550490490436055 · Cited by 468
Cubells, J., Rayport, S., Rajendran, G., & Sulzer, D. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-04-02260.1994 · Cited by 448
LaVoie, M. J., & Hastings, T. G. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-04-01484.1999 · Cited by 447
Methamphetamine use behaviors and gender differences
Brecht, M.-L., O'Brien, A., von Mayrhauser, C., & Anglin, M. D. (2004) · Addictive Behaviors · doi:10.1016/s0306-4603(03)00082-0 · Cited by 443
Hotchkiss, A. J., & Gibb, J. W. (1980) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32165-8 · Cited by 442
Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons
RIPPETH, J. D., HEATON, R. K., CAREY, C. L., MARCOTTE, T. D., MOORE, D. J., GONZALEZ, R., WOLFSON, T., GRANT, I., & GROUP, T. H. (2004) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617704101021 · Cited by 435
The need for speed: an update on methamphetamine addiction
Barr, A. M., Panenka, W. J., MacEwan, G. W., Thornton, A. E., Lang, D. J., Honer, W. G., & Lecomte, T. (2006) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0635 · Cited by 434
Structural and metabolic brain changes in the striatum associated with methamphetamine abuse
Chang, L., Alicata, D., Ernst, T., & Volkow, N. (2007) · Addiction · doi:10.1111/j.1360-0443.2006.01782.x · Cited by 430
Further studies of the role of hyperthermia in methamphetamine neurotoxicity.
Bowyer, J. F., Davies, D. L., Schmued, L., Broening, H. W., Newport, G. D., Slikker, W., & Holson, R. R. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38650-7 · Cited by 411
Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse.
O'Callaghan, J. P., & Miller, D. B. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22433-8 · Cited by 409
Implications of Chronic Methamphetamine Use: A Literature Review
Meredith, C. W., Jaffe, C., Ang-Lee, K., & Saxon, A. J. (2005) · Harvard Review of Psychiatry · doi:10.1080/10673220591003605 · Cited by 393
Methamphetamine causes microglial activation in the brains of human abusers
Sekine, Y., Ouchi, Y., Sugihara, G., Takei, N., Yoshikawa, E., Nakamura, K., Iwata, Y., Tsuchiya, K. J., Suda, S., Suzuki, K., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1179-08.2008 · Cited by 381
Self-citationEvidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study
Ernst, T., Chang, L., Leonido–Yee, M., & Speck, O. (2000) · Neurology · doi:10.1212/wnl.54.6.1344 · Cited by 373
Nash, J. F., & Yamamoto, B. K. (1992) · Brain Research · doi:10.1016/0006-8993(92)90713-j · Cited by 354
Larsen, K. E., Fon, E. A., Hastings, T. G., Edwards, R. H., & Sulzer, D. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-20-08951.2002 · Cited by 335
VERDEJO-GARCÍA, A., BECHARA, A., RECKNOR, E. C., & PÉREZ-GARCÍA, M. (2006) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617706060486 · Cited by 315
Thomas, D. M., Walker, P. D., Benjamins, J. A., Geddes, T. J., & Kuhn, D. M. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.070961 · Cited by 315
Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys
Seiden, L. S., Fischman, M. W., & Schuster, C. R. (1976) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(76)90030-2 · Cited by 307
Homer, B. D., Solomon, T. M., Moeller, R. W., Mascia, A., DeRaleau, L., & Halkitis, P. N. (2008) · Psychological Bulletin · doi:10.1037/0033-2909.134.2.301 · Cited by 304
Role of dopamine in the neurotoxic effects of methamphetamine.
Schmidt, C. J., Ritter, J. K., Sonsalla, P. K., Hanson, G. R., & Gibb, J. W. (1985) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22853-1 · Cited by 300
Brain Temperature Alters Hydroxyl Radical Production during Cerebral Ischemia/Reperfusion in Rats
Kil, H. Y., Zhang, J., & Piantadosi, C. A. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199601000-00012 · Cited by 291
Brain Serotonin Transporter Density and Aggression in Abstinent Methamphetamine Abusers
Sekine, Y., Ouchi, Y., Takei, N., Yoshikawa, E., Nakamura, K., Futatsubashi, M., Okada, H., Minabe, Y., Suzuki, K., Iwata, Y., et al. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.1.90 · Cited by 287
Paulus, M. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00334-7 · Cited by 283 · cited 2×
“Neuropsychological studies have detected deficits in attention, working memory, and decision-making in chronic METH addicts (Gonzalez et al., 2004; Paulus et al., 2002; Rippeth et al., 2004; Salo et al., 2002; Semple et al., 2005; Sim et al., 2002; Simon et al., 2002, 2004; Verdejo-Garcia et al.,…”
BackgroundGunasekar, P. G., Kanthasamy, A. G., Borowitz, J. L., & Isom, G. E. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65052016.x · Cited by 283
Jayanthi, S., Deng, X., H. Noailles, P., Ladenheim, B., & Lud Cadet, J. (2004) · The FASEB Journal · doi:10.1096/fj.03-0295com · Cited by 278
Methamphetamine‐induced neurotoxicity: Roles for glutamate and dopamine efflux
Stephans, S. E., & Yamamoto, B. K. (1994) · Synapse · doi:10.1002/syn.890170310 · Cited by 278
Neurotoxicity of substituted amphetamines: Molecular and cellular mechanisms
Cadet, J. L., Krasnova, I. N., Jayanthi, S., & Lyles, J. (2007) · Neurotoxicity Research · doi:10.1007/bf03033567 · Cited by 272
Self-citationFas ligand/Fas system in the brain: regulator of immune and apoptotic responses
Choi, C., & Benveniste, E. N. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2003.08.007 · Cited by 270
Methamphetamine-induced neuronal damage: A possible role for free radicals
De Vito, M. J., & Wagner, G. C. (1989) · Neuropharmacology · doi:10.1016/0028-3908(89)90130-5 · Cited by 270
Fumagalli, F., Gainetdinov, R. R., Valenzano, K. J., & Caron, M. G. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-13-04861.1998 · Cited by 266
Regulation of mitochondrial membrane permeabilization by BCL-2 family proteins and caspases
Breckenridge, D. G., & Xue, D. (2004) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2004.09.009 · Cited by 265
Src and Cas Mediate JNK Activation but Not ERK1/2 and p38 Kinases by Reactive Oxygen Species
Yoshizumi, M., Abe, J.-I., Haendeler, J., Huang, Q., & Berk, B. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.16.11706 · Cited by 263
Cadet, J. L., Sheng, P., All, S., Rothman, R., Carlson, E., & Epstein, C. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62010380.x · Cited by 263
Self-citationLotharius, J., Falsig, J., van Beek, J., Payne, S., Dringen, R., Brundin, P., & Leist, M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1746-05.2005 · Cited by 262
Hernández, F., & Avila, J. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7220-x · Cited by 262
Miller, D. B., & O'Callaghan, J. P. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22434-x · Cited by 259
Schepers, R. J. F., Oyler, J. M., Joseph, R. E., Cone, E. J., Moolchan, E. T., & Huestis, M. A. (2003) · Clinical Chemistry · doi:10.1373/49.1.121 · Cited by 259
DNA repair in neurons: So if they don’t divide what's to repair?
Fishel, M. L., Vasko, M. R., & Kelley, M. R. (2007) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2006.06.007 · Cited by 256
Albers, D. S., & Sonsalla, P. K. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12160-5 · Cited by 256
Higher Cortical and Lower Subcortical Metabolism in Detoxified Methamphetamine Abusers
Volkow, N. D., Chang, L., Wang, G.-J., Fowler, J. S., Franceschi, D., Sedler, M. J., Gatley, S. J., Hitzemann, R., Ding, Y.-S., Wong, C., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.3.383 · Cited by 249
Neurotransmitter transporters and their impact on the development of psychopharmacology
Iversen, L. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706428 · Cited by 243
Sriram, K., Miller, D. B., & O'Callaghan, J. P. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03566.x · Cited by 242 · cited 1×
“Nevertheless, because attenuation of microglial activation by itself is not sufficient to protect against METH neurotoxicity (Sriram et al., 2006), much more remains to be done in order to further clarify the role of microglia in psychostimulant-induced terminal degeneration and cell death.”
BackgroundSekine, Y., Minabe, Y., Ouchi, Y., Takei, N., Iyo, M., Nakamura, K., Suzuki, K., Tsukada, H., Okada, H., Yoshikawa, E., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.9.1699 · Cited by 241
Fumagalli, F., Gainetdinov, R. R., Wang, Y.-M., Valenzano, K. J., Miller, G. W., & Caron, M. G. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-07-02424.1999 · Cited by 241
Partial Recovery of Brain Metabolism in Methamphetamine Abusers After Protracted Abstinence
Wang, G.-J., Volkow, N. D., Chang, L., Miller, E., Sedler, M., Hitzemann, R., Zhu, W., Logan, J., Ma, Y., & Fowler, J. S. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.2.242 · Cited by 241
Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs
Cunha-Oliveira, T., Rego, A. C., & Oliveira, C. R. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.03.002 · Cited by 240
Bowyer, J. F., Tank, A. W., Newport, G. D., Slikker, W., Ali, S. F., & Holson, R. R. (1992) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11370-0 · Cited by 233
Cognitive Performance of Current Methamphetamine and Cocaine Abusers
Simon, S. L., Domier, C. P., Sim, T., Richardson, K., Rawson, R. A., & Ling, W. (2001) · Journal of Addictive Diseases · doi:10.1300/j069v21n01_06 · Cited by 228
Li, Y., & Trush, M. A. (1993) · Carcinogenesis · doi:10.1093/carcin/14.7.1303 · Cited by 227
Like cops on the beat: the active role of resting microglia
Raivich, G. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.09.001 · Cited by 225
Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users
Chang, L., Ernst, T., Speck, O., Patel, H., DeSilva, M., Leonido-Yee, M., & Miller, E. N. (2002) · Psychiatry Research: Neuroimaging · doi:10.1016/s0925-4927(02)00004-5 · Cited by 224
Invited Review: Cytokine regulation of fever: studies using gene knockout mice
Leon, L. R. (2002) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01005.2001 · Cited by 224
Jayanthi, S., Deng, X., Ladenheim, B., McCoy, M. T., Cluster, A., Cai, N.-S., & Cadet, J. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404990102 · Cited by 223
Self-citationKogan, F. J., Nichols, W. K., & Gibb, J. W. (1976) · European Journal of Pharmacology · doi:10.1016/0014-2999(76)90090-x · Cited by 216
Mark, K. A., Soghomonian, J.-J., & Yamamoto, B. K. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3597-04.2004 · Cited by 215
Ricaurte, G. A., Seiden, L. S., & Schuster, C. R. (1984) · Brain Research · doi:10.1016/0006-8993(84)91221-6 · Cited by 212
Villemagne, V., Yuan, J., Wong, D. F., Dannals, R. F., Hatzidimitriou, G., Mathews, W. B., Ravert, H. T., Musachio, J., McCann, U. D., & Ricaurte, G. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-01-00419.1998 · Cited by 211
Methamphetamine and the expanding complications of amphetamines.
Albertson, T. E., Derlet, R. W., & Hoozen, B. E. V. (1999) · PubMed Central · Cited by 209
Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users
McCann, U. D., Kuwabara, H., Kumar, A., Palermo, M., Abbey, R., Brasic, J., Ye, W., Alexander, M., Dannals, R. F., Wong, D. F., et al. (2008) · Synapse · doi:10.1002/syn.20471 · Cited by 206
Long-term effects of chronic methamphetamine administration in rhesus monkeys
Woolverton, W. L., Ricaurte, G. A., Forno, L. S., & Seiden, L. S. (1989) · Brain Research · doi:10.1016/0006-8993(89)91279-1 · Cited by 205
Microglial activation precedes dopamine terminal pathology in methamphetamine-induced neurotoxicity
LaVoie, M. J., Card, J. P., & Hastings, T. G. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.01.010 · Cited by 204
Giovanni, A., Liang, L. P., Hastings, T. G., & Zigmond, M. J. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64041819.x · Cited by 202
Deng, X., Wang, Y., Chou, J., & Cadet, J. L. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00184-x · Cited by 199
Self-citationReaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter
Whitehead, R. E., Ferrer, J. V., Javitch, J. A., & Justice, J. B. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00125.x · Cited by 194
Microglial activation is a pharmacologically specific marker for the neurotoxic amphetamines
Thomas, D. M., Dowgiert, J., Geddes, T. J., Francescutti-Verbeem, D., Liu, X., & Kuhn, D. M. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.06.065 · Cited by 193
Shoptaw, S., & Reback, C. J. (2007) · Addiction · doi:10.1111/j.1360-0443.2006.01775.x · Cited by 191
Fornai, F., Lenzi, P., Gesi, M., Ferrucci, M., Lazzeri, G., Busceti, C. L., Ruffoli, R., Soldani, P., Ruggieri, S., Alessandrì, M. G., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-26-08955.2003 · Cited by 190
Hotchkiss, A. J., Morgan, M. E., & Gibb, J. W. (1979) · Life Sciences · doi:10.1016/0024-3205(79)90414-4 · Cited by 190
Integrin signaling in epithelial cells
Gilcrease, M. Z. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.03.031 · Cited by 190
Preliminary evidence of reduced cognitive inhibition in methamphetamine-dependent individuals
Salo, R., Nordahl, T. E., Possin, K., Leamon, M., Gibson, D. R., Galloway, G. P., Flynn, N. M., Henik, A., Pfefferbaum, A., & Sullivan, E. V. (2002) · Psychiatry Research · doi:10.1016/s0165-1781(02)00111-7 · Cited by 188
Itzhak, Y., & Ali, S. F. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67041770.x · Cited by 184
Sonsalla, P. K., Riordan, D. E., & Heikkila, R. E. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22956-1 · Cited by 184
Kuhn, D. M., Arthur, R. E., Thomas, D. M., & Elferink, L. A. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731309.x · Cited by 183
Chuang, D.-M. (2004) · Critical Reviews™ in Neurobiology · doi:10.1615/critrevneurobiol.v16.i12.90 · Cited by 180
Nash, J. F., Meltzer, H. Y., & Gudelsky, G. A. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24086-1 · Cited by 179
IMAM, S. Z., EL‐YAZAL, J., NEWPORT, G. D., ITZHAK, Y., CADET, J. L., SLIKKER, W., & ALI, S. F. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03646.x · Cited by 173
Self-citationGeneral versus Specific Actions of Mild-Moderate Hypothermia in Attenuating Cerebral Ischemic Damage
Zhao, H., Steinberg, G. K., & Sapolsky, R. M. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600540 · Cited by 173
Gluck, M. R., Moy, L. Y., Jayatilleke, E., Hogan, K. A., Manzino, L., & Sonsalla, P. K. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00549.x · Cited by 167
Alterations in Blood–Brain Barrier Function by Morphine and Methamphetamine
Sharma, H. S., & Ali, S. F. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1369.020 · Cited by 167
JAYANTHI, S., DENG, X., BORDELON, M., MCCOY, M. T., & CADET, J. L. (2001) · The FASEB Journal · doi:10.1096/fj.01-0025com · Cited by 165
Self-citationBurrows, K. B., Gudelsky, G. A., & Yamamoto, B. K. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00264-8 · Cited by 164
Why is parkinsonism not a feature of human methamphetamine users?
Moszczyńska, A., Fitzmaurice, P. S., Ang, L. C., Kalasinsky, K. S., Schmunk, G. A., Peretti, F. J., Aiken, S. S., Wickham, D. J., & Kish, S. J. (2004) · Brain · doi:10.1093/brain/awh046 · Cited by 163
Bowyer, J. F., & Ali, S. (2006) · Synapse · doi:10.1002/syn.20324 · Cited by 162
Different glial response to methamphetamine- and methylenedioxymethamphetamine-induced neurotoxicity
Pubill, D., Canudas, A. M., Pallàs, M., Camins, A., Camarasa, J., & Escubedo, E. (2003) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-003-0747-y · Cited by 160
Methamphetamine-related stroke: four cases
Perez, J. A., Arsura, E. L., & Strategos, S. (1999) · The Journal of Emergency Medicine · doi:10.1016/s0736-4679(99)00009-8 · Cited by 160
Zhang, L., Kitaichi, K., Fujimoto, Y., Nakayama, H., Shimizu, E., Iyo, M., & Hashimoto, K. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.05.015 · Cited by 159
Maxwell, J. C., & Rutkowski, B. A. (2008) · Drug and Alcohol Review · doi:10.1080/09595230801919460 · Cited by 154
Friedman, S. D., Castañeda, E., & Hodge, G. K. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00066-5 · Cited by 153
Itzhak, Y., Gandia, C. E., Huang, P. L., & Ali, S. F. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37339-2 · Cited by 153
Attentional Control and Brain Metabolite Levels in Methamphetamine Abusers
Salo, R. E., NORDAHL, T. E., Natsuaki, Y., Leamon, M. H., Galloway, G. P., Waters, C., Moore, C. D., & Buonocore, M. H. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.031 · Cited by 151
Abekawa, T., Ohmori, T., & Koyama, T. (1994) · Brain Research · doi:10.1016/0006-8993(94)90033-7 · Cited by 149
Fukami, G., Hashimoto, K., Koike, K., Okamura, N., Shimizu, E., & Iyo, M. (2004) · Brain Research · doi:10.1016/j.brainres.2004.04.072 · Cited by 149
Battaglia, G., Fornai, F., Busceti, C. L., Aloisi, G., Cerrito, F., Blasi, A. D., Melchiorri, D., & Nicoletti, F. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-06-02135.2002 · Cited by 148
Neurocognitive performance of methamphetamine users discordant for history of marijuana exposure
González, R., Rippeth, J. D., Carey, C. L., Heaton, R. K., Moore, D. J., Schweinsburg, B. C., Cherner, M., & Grant, I. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.04.014 · Cited by 146
Sonsalla, P. K., Gibb, J. W., & Hanson, G. R. (1986) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24344-0 · Cited by 146
The effect of relapse on cognition in abstinent methamphetamine abusers
Simon, S. L., Dacey, J., Glynn, S., Rawson, R., & Ling, W. (2004) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2004.03.011 · Cited by 142
Jayanthi, S., Ladenheim, B., & Cadet, J. L. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb08224.x · Cited by 141
Self-citationPsychophysiological Aspects of Amphetamine-Methamphetamine Abuse
Murray, J. B. (1998) · The Journal of Psychology · doi:10.1080/00223989809599162 · Cited by 140
Wu, C.-W., Ping, Y., Yen, J., Chang, C., Wang, S., Yeh, C.-L., Chi, C., & Lee, H. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.01.011 · Cited by 140
Signalling pathways mediating inflammatory responses in brain ischaemia
Planas, A. M., Gorina, R., & Chamorro, Á. (2006) · Biochemical Society Transactions · doi:10.1042/bst0341267 · Cited by 138
Woods, S. P., Rippeth, J. D., Conover, E., Gongvatana, A., González, R., Carey, C. L., Cherner, M., Heaton, R. K., & Grant, I. (2005) · Neuropsychology · doi:10.1037/0894-4105.19.1.35 · Cited by 137
Thomas, D. M., & Kuhn, D. M. (2005) · Brain Research · doi:10.1016/j.brainres.2005.05.049 · Cited by 137
Impulsivity and methamphetamine use
Semple, S. J., Zians, J., Grant, I., & Patterson, T. L. (2005) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2005.05.001 · Cited by 137
Cadet, J. L., Jayanthi, S., & Deng, X. (2005) · Neurotoxicity Research · doi:10.1007/bf03033973 · Cited by 135
Self-citationAmphetamine Neurotoxicity: Cause and Consequence of Oxidative Stress
Yamamoto, B. K., & Bankson, M. G. (2005) · Critical Reviews in Neurobiology · doi:10.1615/critrevneurobiol.v17.i2.30 · Cited by 134
Feng, W., Webb, P., Nguyen, P. T., Liu, X., Li, J., Karin, M., & Kushner, P. J. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.1.0590 · Cited by 134
Methamphetamine produces neuronal inclusions in the nigrostriatal system and in PC12 cells
Fornai, F., Lenzi, P., Gesi, M., Soldani, P., Ferrucci, M., Lazzeri, G., Capobianco, L., Battaglia, G., Blasi, A. D., Nicoletti, F., et al. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02137.x · Cited by 133
Thomas, D. M., Francescutti, D. M., & Kuhn, D. M. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05155.x · Cited by 133
Deng, X., Cai, N.-S., McCoy, M. T., Chen, W., Trush, M. A., & Cadet, J. L. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00034-5 · Cited by 132
Self-citationGuilarte, T. R., Nihei, M. K., McGlothan, J. L., & Howard, A. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00476-7 · Cited by 132
Kiyatkin, E. A., Brown, P. L., & Sharma, H. S. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05741.x · Cited by 132
Ladenheim, B., Krasnova, I. N., Deng, X., Oyler, J. M., Polettini, A., Moran, T. H., Huestis, M. A., & Cadet, J. L. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.6.1247 · Cited by 131 · cited 18×
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript METH treatment regimen Time-points after METH injections Tissue Data obtained Reference followed by 7.5 mg/kg, 3 times, every 2 h Yamamoto, 1996 12.5 mg/kg, 4 times, 2 h apart 48 and 237 days Caudate ↓DA levels Friedman et al., 1998 48…”
BackgroundResultInfluentialSelf-citationSegal, D. S., & Kuczenski, R. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36838-7 · Cited by 131
Methamphetamine exposure can produce neuronal degeneration in mouse hippocampal remnants
Schmued, L. C., & Bowyer, J. F. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00173-x · Cited by 131
Cadet, J. L., Ordonez, S., & Ordóñez, J. V. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199702)25:2<176::aid-syn8>3.0.co;2-9 · Cited by 130
Self-citationGibb, J. W., & Kogan, F. J. (1979) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00500283 · Cited by 129
Melega, W. P., Raleigh, M. J., Stout, D. B., Laćan, G., Huang, S.-C., & Phelps, M. E. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00548-9 · Cited by 126
Schmidt, C. J., & Gibb, J. W. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90541-2 · Cited by 124
Marek, G. J., Vosmer, G. L., & Seiden, L. S. (1990) · Brain Research · doi:10.1016/0006-8993(90)90467-p · Cited by 124
Zafar, K. S., Siegel, D. M., & Ross, D. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.024703 · Cited by 124
Eisch, A. J., & Marshall, J. F. (1998) · Synapse · doi:10.1002/(sici)1098-2396(199812)30:4<433::aid-syn10>3.0.co;2-o · Cited by 120
Xie, T., McCann, U. D., Kim, S., Yuan, J., & Ricaurte, G. A. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-20-07838.2000 · Cited by 120
Zhu, J. P. Q., Xu, W., & Angulo, J. A. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.02.055 · Cited by 119
Methamphetamine-induced changes in brain catecholamines in rats and guinea pigs
Wagner, G. C., Seiden, L. S., & Schuster, C. R. (1979) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(79)90076-0 · Cited by 119
SHARMA, H. S., & Kiyatkin, E. A. (2008) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2008.08.002 · Cited by 118
Segal, D. S., Kuczenski, R. T., O’Neil, M. L., Melega, W. P., & Cho, A. K. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300247 · Cited by 117
Hirata, H., Ladenheim, B., Carlson, E. J., Epstein, C. J., & Cadet, J. L. (1996) · Brain Research · doi:10.1016/0006-8993(95)01502-7 · Cited by 117
Self-citationSuppression of autophagy precipitates neuronal cell death following low doses of methamphetamine
Castino, R., Lazzeri, G., Lenzi, P., Bellio, N., Follo, C., Ferrucci, M., Fornai, F., & Isidoro, C. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05488.x · Cited by 115
Null Mutation of c-fos Causes Exacerbation of Methamphetamine-Induced Neurotoxicity
Deng, X., Ladenheim, B., Tsao, L.-I., & Cadet, J. L. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-22-10107.1999 · Cited by 114
Self-citationPyrogenic and thermogenic effects of interleukin 1 beta in the rat
Dascombe, M. J., Rothwell, N. J., Sagay, B. O., & Stock, M. J. (1989) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1989.256.1.e7 · Cited by 112
Spencer, J. P. E., Whiteman, M., Jenner, P. G., & Halliwell, B. B. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00808.x · Cited by 111
Imam, S. Z., Newport, G. D., Itzhak, Y., Cadet, J. L., Islam, F., Slikker, W., & Ali, S. F. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00029.x · Cited by 111
Self-citationMiyazaki, I., Asanuma, M., Diaz-Corrales, F. J. J., Fukuda, M., Kitaichi, K., Miyoshi, K., & Ogawa, N. (2006) · The FASEB Journal · doi:10.1096/fj.05-4996fje · Cited by 111
Long-Term Changes in Basal Ganglia Function after a Neurotoxic Regimen of Methamphetamine
Chapman, D. E., Hanson, G. R., Kesner, R. P., & Keefe, K. A. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38769-5 · Cited by 111
Stroke Associated with Methamphetamine Inhalation
Yen, D., Wang, S., Ju, T.-H., Chen, C. C., Liao, K. K., Fuh, J., & Hu, H. (2008) · European Neurology · doi:10.1159/000117002 · Cited by 110
Role of glutamate in neurodegeneration of dopamine neurons in several animal models of parkinsonism
Sonsalla, P. K., Albers, D. S., & Zeevalk, G. D. (1998) · Amino Acids · doi:10.1007/bf01345245 · Cited by 110
Fukumura, M., Cappon, G. D., Pu, C., Broening, H. W., & Vorhees, C. V. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00656-8 · Cited by 110
Farfel, G. M., & Seiden, L. S. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24411-1 · Cited by 110
Farfel, G. M., & Seiden, L. S. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24505-0 · Cited by 108
Immunocytochemical evidence for methamphetamine‐induced serotonergic axon loss in the rat brain
Axt, K. J., & Molliver, M. E. (1991) · Synapse · doi:10.1002/syn.890090405 · Cited by 106
O’Dell, S. J., Weihmuller, F. B., & Marshall, J. F. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb13405.x · Cited by 105
Alpha-methyltyrosine attenuates and reserpine increases methamphetamine-induced neuronal changes
Wagner, G. C., Lucot, J. B., Schuster, C. R., & Seiden, L. S. (1983) · Brain Research · doi:10.1016/0006-8993(83)90602-9 · Cited by 104
Methamphetamine‐induced inhibition of mitochondrial complex II: roles of glutamate and peroxynitrite
Brown, J. M., Quinton, M. S., & Yamamoto, B. K. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03379.x · Cited by 103
Cadet, J. L., Jayanthi, S., McCoy, M. T., Vawter, M. P., & Ladenheim, B. (2001) · Synapse · doi:10.1002/syn.1058 · Cited by 103
Self-citationBrain serotonin transporter in human methamphetamine users
Kish, S. J., Fitzmaurice, P. S., Boileau, I., Schmunk, G. A., Ang, L.-C., Furukawa, Y., Chang, L., Wickham, D. J., Sherwin, A. L., & Tong, J. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1346-x · Cited by 103
Sandoval, V., Riddle, E. L., Hanson, G. R., & Fleckenstein, A. E. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.045005 · Cited by 103
Fantegrossi, W. E., Ciullo, J. R., Wakabayashi, K. T., Garza, R. D. L., Traynor, J. R., & Woods, J. H. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.11.007 · Cited by 102
Aron, J. L., & Paulus, M. P. (2007) · Addiction · doi:10.1111/j.1360-0443.2006.01778.x · Cited by 102
Attenuated microglial activation mediates tolerance to the neurotoxic effects of methamphetamine
Thomas, D. M., & Kuhn, D. M. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02906.x · Cited by 101
Xiang, Z., Haroutunian, V., Ho, L., Purohit, D., & Pasinetti, G. M. (2006) · Disease Markers · doi:10.1155/2006/276239 · Cited by 101
Dopamine induces proteasome inhibition in neural PC12 cell line
Keller, J. N., Huang, F. F., Dimayuga, E. R., & Maragos, W. F. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00412-3 · Cited by 99
Jiménez, A., Jordà, E. G., Verdaguer, E., Pubill, D., Sureda, F. X., Canudas, A. M., Escubedo, E., Camarasa, J., Camins, A., & Pallàs, M. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2003.12.017 · Cited by 98
Kuczenski, R. T., Everall, I., Crews, L. A., Adame, A., GRANT, I., & Masliah, E. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.05.023 · Cited by 98
The Metabolism of Amphetamines in Mammals
Caldwell, J. (1976) · Drug Metabolism Reviews · doi:10.3109/03602537609029979 · Cited by 98
Bowyer, J. F., Robinson, B. L., Ali, S. F., & Schmued, L. C. (2007) · Synapse · doi:10.1002/syn.20478 · Cited by 97
Bakhit, C., Morgan, M. E., Peat, M., & Gibb, J. W. (1981) · Neuropharmacology · doi:10.1016/0028-3908(81)90053-8 · Cited by 94
Monte, D. A. D., Royland, J. E., Jakowec, M. W., et al. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67062443.x · Cited by 94
Lorez, H. (1981) · Life Sciences · doi:10.1016/0024-3205(81)90053-9 · Cited by 93
Dopamine-glutamate interactions in methamphetaminc-induced neurotoxicity
Marshall, J. F., O’Dell, S. J., & Weihmuller, F. B. (1993) · Journal of Neural Transmission · doi:10.1007/bf01245234 · Cited by 93
Sharma, H. S., Sjöquist, P.-O. B., & Ali, S. F. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207780858375 · Cited by 93
Thomas, D. M., Francescutti, D. M., Liu, X., & Kuhn, D. M. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02182.x · Cited by 91
An Emerging Problem: Methamphetamine Abuse Among Treatment Seeking Youth
Gonzales, R. E., Ang, A., McCann, M., & Rawson, R. A. (2008) · Substance Abuse · doi:10.1080/08897070802093312 · Cited by 91
Neuropeptide Y Protects against Methamphetamine-Induced Neuronal Apoptosis in the Mouse Striatum
Thiriet, N., Deng, X., Solinas, M., Ladenheim, B., Curtis, W., Goldberg, S. R., Palmiter, R. D., & Cadet, J. L. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4893-04.2005 · Cited by 91
Self-citationMethamphetamine-enhanced embryonic oxidative DNA damage and neurodevelopmental deficits
Jeng, W., Wong, A. W., Ting‐A‐Kee, R. A., & Wells, P. G. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.03.015 · Cited by 91
Sekine, Y., Minabe, Y., Kawai, M., Suzuki, K., Iyo, M., Isoda, H., Sakahara, H., Ashby, C. R., Takei, N., & Mori, N. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00321-4 · Cited by 90
Deng, X., & Cadet, J. L. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00169-8 · Cited by 89
Self-citationFitzmaurice, P. S., Tong, J., Yazdanpanah, M., Liu, P. P., Kalasinsky, K. S., & Kish, S. J. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.109173 · Cited by 89
Preston, K. L., Wagner, G. C., Schuster, C. R., & Seiden, L. S. (1985) · Brain Research · doi:10.1016/0006-8993(85)90153-2 · Cited by 87
Cited by
A Guide to Neurotoxic Animal Models of Parkinson's Disease
Tieu, K. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009316 · Cited by 483
Methamphetamine use: A comprehensive review of molecular, preclinical and clinical findings
Panenka, W. J., Procyshyn, R. M., Lecomte, T., MacEwan, G. W., Flynn, S. W., Honer, W. G., & Barr, A. M. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.11.016 · Cited by 432
Toxicity of amphetamines: an update
Carvalho, M., Carmo, H., Costa, V. M., Capela, J. P., Pontes, H., Remião, F., Carvalho, F., & Bastos, M. D. L. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0815-5 · Cited by 431
kappa-Opioid receptor signaling and brain reward function
Bruijnzeel, A. W. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.09.008 · Cited by 214
Decreased dopamine activity predicts relapse in methamphetamine abusers
Wang, G. J., Smith, L., Volkow, N. D., Telang, F., Logan, J., Tomasi, D., Wong, C. T., Hoffman, W., Jayne, M., Alia-Klein, N., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.86 · Cited by 214
Metadata
- Authors
- Krasnova, I. N., & Cadet, J. L.
- Venue
- Brain Research Reviews
- Publisher
- Elsevier BV
- Published
- 2009-05
- Volume
- 60
- Issue
- 2
- Pages
- 379-407
- ISSN
- 0165-0173 (ISSN-L)
- OpenAlex
- W2154345916
- Cited by
- 589
- References
- 326
- FWCI
- 15.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.